{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:59:46Z","timestamp":1773781186284,"version":"3.50.1"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"DOI":"10.7759\/cureus.86891","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T05:52:27Z","timestamp":1751089947000},"source":"Crossref","is-referenced-by-count":1,"title":["The Role of Diet in Crohn\u2019s Disease: From Etiology to Evidence-Based Management"],"prefix":"10.7759","author":[{"given":"Fares","family":"Jamal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayar H","family":"Alatout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed B","family":"Pasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talha A","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang JT","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020, 383:2652-64. 10.1056\/NEJMra2002697","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19 Suppl A","author":"Silverberg MS","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et al.. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005, 19 Suppl A:5A-36A. 10.1155\/2005\/269076","journal-title":"Can J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn's disease in adults","volume":"113","author":"Lichtenstein GR","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018, 113:481-517. 10.1038\/ajg.2018.27","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-10-200111200-00011","article-title":"Diagnosis and treatment of perianal fistulas in Crohn disease","volume":"135","author":"Schwartz DA","year":"2001","unstructured":"Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fistulas in Crohn disease. Ann Intern Med. 2001, 135:906-18. 10.7326\/0003-4819-135-10-200111200-00011","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0884533615606898","article-title":"Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet?","volume":"30","author":"Serban DE","year":"2015","unstructured":"Serban DE. Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet?. Nutr Clin Pract. 2015, 30:760-79. 10.1177\/0884533615606898","journal-title":"Nutr Clin Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky NA","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, et al.. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012, 142:46-54.e42; quiz e30. 10.1053\/j.gastro.2011.10.001","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14563","article-title":"Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: an Epi-IBD study","volume":"34","author":"Burisch J","year":"2019","unstructured":"Burisch J, Zammit SC, Ellul P, et al.. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: an Epi-IBD study. J Gastroenterol Hepatol. 2019, 34:996-1003. 10.1111\/jgh.14563","journal-title":"J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61183-X","article-title":"Infant mortality and the incidence of inflammatory bowel disease","volume":"349","author":"Montgomery SM","year":"1997","unstructured":"Montgomery SM, Pounder RE, Wakefield AJ. Infant mortality and the incidence of inflammatory bowel disease. Lancet. 1997, 349:472-3. 10.1016\/S0140-6736(05)61183-X","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan GG","year":"2017","unstructured":"Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017, 152:313-21.e2. 10.1053\/j.gastro.2016.10.020","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan GG","year":"2015","unstructured":"Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015, 12:720-7. 10.1038\/nrgastro.2015.150","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng SC","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al.. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017, 390:2769-78. 10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-023-01944-2","article-title":"Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)","volume":"23","author":"Mak JW","year":"2023","unstructured":"Mak JW, Sun Y, Limsrivilai J, et al.. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21). BMC Med Res Methodol. 2023, 23:129. 10.1186\/s12874-023-01944-2","journal-title":"BMC Med Res Methodol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12859","article-title":"Emerging leadership lecture: inflammatory bowel disease in Asia: emergence of a \"Western\" disease","volume":"30","author":"Ng SC","year":"2015","unstructured":"Ng SC. Emerging leadership lecture: inflammatory bowel disease in Asia: emergence of a \"Western\" disease. J Gastroenterol Hepatol. 2015, 30:440-5. 10.1111\/jgh.12859","journal-title":"J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13050","article-title":"Never underestimate inflammatory bowel disease: high prevalence rates and confirmation of high incidence rates in Australia","volume":"31","author":"Studd C","year":"2016","unstructured":"Studd C, Cameron G, Beswick L, et al.. Never underestimate inflammatory bowel disease: high prevalence rates and confirmation of high incidence rates in Australia. J Gastroenterol Hepatol. 2016, 31:81-6. 10.1111\/jgh.13050","journal-title":"J Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000231572.88806.b9","article-title":"High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study","volume":"12","author":"Gearry RB","year":"2006","unstructured":"Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA, Barclay ML. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis. 2006, 12:936-43. 10.1097\/01.mib.0000231572.88806.b9","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200312000-00004","article-title":"Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England","volume":"15","author":"Stone MA","year":"2003","unstructured":"Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol. 2003, 15:1275-80. 10.1097\/00042737-200312000-00004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12528","article-title":"Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study","volume":"39","author":"B\u00fcsch K","year":"2014","unstructured":"B\u00fcsch K, Ludvigsson JF, Ekstr\u00f6m-Smedby K, Ekbom A, Askling J, Neovius M. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther. 2014, 39:57-68. 10.1111\/apt.12528","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.07.012","article-title":"Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: a population-based study based on the National Health Insurance Fund database","volume":"48","author":"Kurti Z","year":"2016","unstructured":"Kurti Z, Vegh Z, Golovics PA, et al.. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: a population-based study based on the National Health Insurance Fund database. Dig Liver Dis. 2016, 48:1302-7. 10.1016\/j.dld.2016.07.012","journal-title":"Dig Liver Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.962605","article-title":"Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort","volume":"49","author":"Hein R","year":"2014","unstructured":"Hein R, K\u00f6ster I, Bollschweiler E, Schubert I. Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort. Scand J Gastroenterol. 2014, 49:1325-35. 10.3109\/00365521.2014.962605","journal-title":"Scand J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200606000-00005","article-title":"Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002","volume":"18","author":"Jacobsen BA","year":"2006","unstructured":"Jacobsen BA, Fallingborg J, Rasmussen HH, et al.. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol. 2006, 18:601-6. 10.1097\/00042737-200606000-00005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar R","year":"2017","unstructured":"Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol. 2017, 15:857-63. 10.1016\/j.cgh.2016.10.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000103","article-title":"Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends","volume":"20","author":"Benchimol EI","year":"2014","unstructured":"Benchimol EI, Manuel DG, Guttmann A, Nguyen GC, Mojaverian N, Quach P, Mack DR. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis. 2014, 20:1761-9. 10.1097\/MIB.0000000000000103","journal-title":"Inflamm Bowel Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1128","article-title":"Analysis of circulating tumor DNA and clinical correlates in patients with esophageal, gastroesophageal junction, and gastric adenocarcinoma","volume":"24","author":"Kato S","year":"2018","unstructured":"Kato S, Okamura R, Baumgartner JM, et al.. Analysis of circulating tumor DNA and clinical correlates in patients with esophageal, gastroesophageal junction, and gastric adenocarcinoma. Clin Cancer Res. 2018, 24:6248-56. 10.1158\/1078-0432.CCR-18-1128","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.04.021","article-title":"Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial","volume":"157","author":"Levine A","year":"2019","unstructured":"Levine A, Wine E, Assa A, et al.. Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology. 2019, 157:440-50.e8. 10.1053\/j.gastro.2019.04.021","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02857-6","article-title":"Efficacy of Crohn's disease exclusion diet in treatment -na\u00efve children and children progressed on biological therapy: a retrospective chart review","volume":"23","author":"Jij\u00f3n Andrade MC","year":"2023","unstructured":"Jij\u00f3n Andrade MC, Pujol Muncunill G, Lozano Ruf A, et al.. Efficacy of Crohn's disease exclusion diet in treatment -na\u00efve children and children progressed on biological therapy: a retrospective chart review. BMC Gastroenterol. 2023, 23:225. 10.1186\/s12876-023-02857-6","journal-title":"BMC Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.12.006","article-title":"Modified Crohn's disease exclusion diet maintains remission in pediatric crohn's disease: randomized controlled trial","author":"Sigall Boneh R","year":"2024","unstructured":"Sigall Boneh R, Navas-L\u00f3pez VM, Hussey S, et al.. Modified Crohn's disease exclusion diet maintains remission in pediatric crohn's disease: randomized controlled trial. Clin Gastroenterol Hepatol. 2024, 10.1016\/j.cgh.2024.12.006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan Q","year":"2019","unstructured":"Guan Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019, 2019:7247238. 10.1155\/2019\/7247238","journal-title":"J Immunol Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300777","article-title":"Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project","volume":"62","author":"Cleynen I","year":"2013","unstructured":"Cleynen I, Gonz\u00e1lez JR, Figueroa C, et al.. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut. 2013, 62:1556-65. 10.1136\/gutjnl-2011-300777","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-019-03441-9","article-title":"Role of environmental factors in the pathogenesis of Crohn's disease: a critical review","volume":"34","author":"Chen Y","year":"2019","unstructured":"Chen Y, Wang Y, Shen J. Role of environmental factors in the pathogenesis of Crohn's disease: a critical review. Int J Colorectal Dis. 2019, 34:2023-34. 10.1007\/s00384-019-03441-9","journal-title":"Int J Colorectal Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Strober W","year":"2011","unstructured":"Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011, 140:1756-67. 10.1053\/j.gastro.2011.02.016","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000096","article-title":"Crohn's disease-associated Escherichia coli survive in macrophages by suppressing NF\u03baB signaling","volume":"20","author":"Rahman K","year":"2014","unstructured":"Rahman K, Sasaki M, Nusrat A, Klapproth JM. Crohn's disease-associated Escherichia coli survive in macrophages by suppressing NF\u03baB signaling. Inflamm Bowel Dis. 2014, 20:1419-25. 10.1097\/MIB.0000000000000096","journal-title":"Inflamm Bowel Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04365-8","article-title":"IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes","volume":"9","author":"Momozawa Y","year":"2018","unstructured":"Momozawa Y, Dmitrieva J, Th\u00e9\u00e2tre E, et al.. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nat Commun. 2018, 9:2427. 10.1038\/s41467-018-04365-8","journal-title":"Nat Commun"},{"key":"ref33","article-title":"High-density lipoprotein cholesterol--an epidemiologic reappraisal [Article in Hebrew]","volume":"116","author":"Goldbourt U","year":"1989","unstructured":"Goldbourt U. High-density lipoprotein cholesterol--an epidemiologic reappraisal [Article in Hebrew]. Harefuah. 1989, 116:172-5.","journal-title":"Harefuah"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae075","article-title":"NOD2 and Crohn's disease clinical practice: from epidemiology to diagnosis and therapy, rewired","volume":"31","author":"Kayali S","year":"2025","unstructured":"Kayali S, Fantasia S, Gaiani F, Cavallaro LG, de'Angelis GL, Laghi L. NOD2 and Crohn's disease clinical practice: from epidemiology to diagnosis and therapy, rewired. Inflamm Bowel Dis. 2025, 31:552-62. 10.1093\/ibd\/izae075","journal-title":"Inflamm Bowel Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.006","article-title":"ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis","volume":"139","author":"Homer CR","year":"2010","unstructured":"Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology. 2010, 139:1630-41.e1-2. 10.1053\/j.gastro.2010.07.006","journal-title":"Gastroenterology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13511","article-title":"Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease","volume":"43","author":"To N","year":"2016","unstructured":"To N, Gracie DJ, Ford AC. Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease. Aliment Pharmacol Ther. 2016, 43:549-61. 10.1111\/apt.13511","journal-title":"Aliment Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00074","article-title":"Impact of cigarette smoking on the gastrointestinal tract inflammation: opposing effects in Crohn's disease and ulcerative colitis","volume":"9","author":"Berkowitz L","year":"2018","unstructured":"Berkowitz L, Schultz BM, Salazar GA, Pardo-Roa C, Sebasti\u00e1n VP, \u00c1lvarez-Lobos MM, Bueno SM. Impact of cigarette smoking on the gastrointestinal tract inflammation: opposing effects in Crohn's disease and ulcerative colitis. Front Immunol. 2018, 9:74. 10.3389\/fimmu.2018.00074","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i27.6296","article-title":"Environmental risk factors for inflammatory bowel diseases: evidence based literature review","volume":"22","author":"Abegunde AT","year":"2016","unstructured":"Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: evidence based literature review. World J Gastroenterol. 2016, 22:6296-317. 10.3748\/wjg.v22.i27.6296","journal-title":"World J Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2024.100219","article-title":"Diet, food, and nutritional exposures and inflammatory bowel disease or progression of disease: an umbrella review","volume":"15","author":"Christensen C","year":"2024","unstructured":"Christensen C, Knudsen A, Arnesen EK, Hatlebakk JG, Sletten IS, Fadnes LT. Diet, food, and nutritional exposures and inflammatory bowel disease or progression of disease: an umbrella review. Adv Nutr. 2024, 15:100219. 10.1016\/j.advnut.2024.100219","journal-title":"Adv Nutr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa018","article-title":"Dietary patterns, ultra-processed food, and the risk of inflammatory bowel diseases in the NutriNet-Sant\u00e9 Cohort","volume":"27","author":"Vasseur P","year":"2021","unstructured":"Vasseur P, Dugelay E, Benamouzig R, et al.. Dietary patterns, ultra-processed food, and the risk of inflammatory bowel diseases in the NutriNet-Sant\u00e9 Cohort. Inflamm Bowel Dis. 2021, 27:65-73. 10.1093\/ibd\/izaa018","journal-title":"Inflamm Bowel Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.20960\/nh.05460","article-title":"Role of diet in the prevention and development of Crohn's Disease [Article in Spanish]","volume":"41","author":"Mart\u00ednez-Garc\u00eda RM","year":"2024","unstructured":"Mart\u00ednez-Garc\u00eda RM, Jim\u00e9nez-Ortega AI, Salas-Gonz\u00e1lez MD, Peral-Su\u00e1rez \u00c1, Ruiz Mart\u00ednez P. Role of diet in the prevention and development of Crohn's Disease [Article in Spanish]. Nutr Hosp. 2024, 41:57-61. 10.20960\/nh.05460","journal-title":"Nutr Hosp"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330971","article-title":"Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts","volume":"73","author":"Guo A","year":"2024","unstructured":"Guo A, Ludvigsson J, Brants\u00e6ter AL, Klingberg S, \u00d6stensson M, St\u00f8rdal K, M\u00e5rild K. Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts. Gut. 2024, 73:590-600. 10.1136\/gutjnl-2023-330971","journal-title":"Gut"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100573","article-title":"A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: the MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design","volume":"18","author":"Peter I","year":"2020","unstructured":"Peter I, Maldonado-Contreras A, Eisele C, et al.. A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: the MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design. Contemp Clin Trials Commun. 2020, 18:100573. 10.1016\/j.conctc.2020.100573","journal-title":"Contemp Clin Trials Commun"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/nu11050947","article-title":"A review of dietary therapy for IBD and a vision for the future","volume":"11","author":"Green N","year":"2019","unstructured":"Green N, Miller T, Suskind D, Lee D. A review of dietary therapy for IBD and a vision for the future. Nutrients. 2019, 11:947. 10.3390\/nu11050947","journal-title":"Nutrients"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-013-0313-9","article-title":"What can we learn from inflammatory bowel disease in developing countries?","volume":"15","author":"Wong SH","year":"2013","unstructured":"Wong SH, Ng SC. What can we learn from inflammatory bowel disease in developing countries?. Curr Gastroenterol Rep. 2013, 15:313. 10.1007\/s11894-013-0313-9","journal-title":"Curr Gastroenterol Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome","volume":"519","author":"Chassaing B","year":"2015","unstructured":"Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015, 519:92-6. 10.1038\/nature14232","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313099","article-title":"Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation","volume":"66","author":"Chassaing B","year":"2017","unstructured":"Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017, 66:1414-27. 10.1136\/gutjnl-2016-313099","journal-title":"Gut"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980017000234","article-title":"The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing","volume":"21","author":"Monteiro CA","year":"2018","unstructured":"Monteiro CA, Cannon G, Moubarac JC, Levy RB, Louzada ML, Jaime PC. The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing. Public Health Nutr. 2018, 21:5-17. 10.1017\/S1368980017000234","journal-title":"Public Health Nutr"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/nu15132890","article-title":"Ultra-processed foods, diet quality and human health","volume":"15","author":"Dinu M","year":"2023","unstructured":"Dinu M, Martini D. Ultra-processed foods, diet quality and human health. Nutrients. 2023, 15:2890. 10.3390\/nu15132890","journal-title":"Nutrients"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s43016-023-00779-w","article-title":"Best practices for applying the Nova food classification system","volume":"4","author":"Martinez-Steele E","year":"2023","unstructured":"Martinez-Steele E, Khandpur N, Batis C, et al.. Best practices for applying the Nova food classification system. Nat Food. 2023, 4:445-8. 10.1038\/s43016-023-00779-w","journal-title":"Nat Food"},{"key":"ref51","article-title":"Nations FaAOotU. The State of Food and Agriculture 2019: Moving forward on food loss and waste reduction","year":"2019","unstructured":"The State of Food and Agriculture 2019. Moving Forward on Food Loss and Waste Reduction. Food and Agriculture Organization of the United Nations, Rome, Italy; 2019. https:\/\/www.fao.org\/3\/ca6030en\/ca6030en.pdf."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00893-5","article-title":"Ultra-processed foods and food additives in gut health and disease","volume":"21","author":"Whelan K","year":"2024","unstructured":"Whelan K, Bancil AS, Lindsay JO, Chassaing B. Ultra-processed foods and food additives in gut health and disease. Nat Rev Gastroenterol Hepatol. 2024, 21:406-27. 10.1038\/s41575-024-00893-5","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1554","article-title":"Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study","volume":"374","author":"Narula N","year":"2021","unstructured":"Narula N, Wong EC, Dehghan M, et al.. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021, 374:n1554. 10.1136\/bmj.n1554","journal-title":"BMJ"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac167","article-title":"Intake of ultra-processed foods is associated with an increased risk of Crohn's disease: a cross-sectional and prospective analysis of 187 154 participants in the UK Biobank","volume":"17","author":"Chen J","year":"2023","unstructured":"Chen J, Wellens J, Kalla R, et al.. Intake of ultra-processed foods is associated with an increased risk of Crohn's disease: a cross-sectional and prospective analysis of 187 154 participants in the UK Biobank. J Crohns Colitis. 2023, 17:535-52. 10.1093\/ecco-jcc\/jjac167","journal-title":"J Crohns Colitis"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.01.012","article-title":"Food processing and risk of inflammatory bowel disease: a\u00a0systematic review and meta-analysis","volume":"21","author":"Narula N","year":"2023","unstructured":"Narula N, Chang NH, Mohammad D, et al.. Food processing and risk of inflammatory bowel disease: a\u00a0systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023, 21:2483-2495.e1. 10.1016\/j.cgh.2023.01.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06224-3","article-title":"Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in mice","volume":"7","author":"Panyod S","year":"2024","unstructured":"Panyod S, Wu WK, Chang CT, et al.. Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in mice. Commun Biol. 2024, 7:749. 10.1038\/s42003-024-06224-3","journal-title":"Commun Biol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9531.127541","article-title":"The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern","volume":"3","author":"Asif M","year":"2014","unstructured":"Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot. 2014, 3:1. 10.4103\/2277-9531.127541","journal-title":"J Educ Health Promot"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13040115","article-title":"Artificial sweeteners: a double-edged sword for gut microbiome","volume":"13","author":"Hetta HF","year":"2025","unstructured":"Hetta HF, Sirag N, Elfadil H, et al.. Artificial sweeteners: a double-edged sword for gut microbiome. Diseases. 2025, 13:115. 10.3390\/diseases13040115","journal-title":"Diseases"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326575","article-title":"Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts","volume":"71","author":"Adolph TE","year":"2022","unstructured":"Adolph TE, Zhang J. Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts. Gut. 2022, 71:2574-86. 10.1136\/gutjnl-2021-326575","journal-title":"Gut"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy060","article-title":"The artificial sweetener splenda promotes gut proteobacteria, dysbiosis, and myeloperoxidase reactivity in Crohn's disease-like ileitis","volume":"24","author":"Rodriguez-Palacios A","year":"2018","unstructured":"Rodriguez-Palacios A, Harding A, Menghini P, et al.. The artificial sweetener splenda promotes gut proteobacteria, dysbiosis, and myeloperoxidase reactivity in Crohn's disease-like ileitis. Inflamm Bowel Dis. 2018, 24:1005-20. 10.1093\/ibd\/izy060","journal-title":"Inflamm Bowel Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05801-6","article-title":"The dietary sweetener sucralose is a negative modulator of T cell-mediated responses","volume":"615","author":"Zani F","year":"2023","unstructured":"Zani F, Blagih J, Gruber T, et al.. The dietary sweetener sucralose is a negative modulator of T cell-mediated responses. Nature. 2023, 615:705-11. 10.1038\/s41586-023-05801-6","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1080\/19440049.2017.1308018","article-title":"Estimated daily intake and safety of FD&C food-colour additives in the US population","volume":"34","author":"Bastaki M","year":"2017","unstructured":"Bastaki M, Farrell T, Bhusari S, Bi X, Scrafford C. Estimated daily intake and safety of FD&C food-colour additives in the US population. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017, 34:891-904. 10.1080\/19440049.2017.1308018","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/srep40373","article-title":"Food-grade TiO(2) impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon","volume":"7","author":"Bettini S","year":"2017","unstructured":"Bettini S, Boutet-Robinet E, Cartier C, et al.. Food-grade TiO(2) impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. Sci Rep. 2017, 7:40373. 10.1038\/srep40373","journal-title":"Sci Rep"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35309-y","article-title":"Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice","volume":"13","author":"Kwon YH","year":"2022","unstructured":"Kwon YH, Banskota S, Wang H, et al.. Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice. Nat Commun. 2022, 13:7617. 10.1038\/s41467-022-35309-y","journal-title":"Nat Commun"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/63.5.741","article-title":"Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan","volume":"63","author":"Shoda R","year":"1996","unstructured":"Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996, 63:741-5. 10.1093\/ajcn\/63.5.741","journal-title":"Am J Clin Nutr"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1990.258.1.H38","article-title":"Modulation of electrophysiological properties of neonatal canine heart by tonic parasympathetic stimulation","volume":"258","author":"Pickoff AS","year":"1990","unstructured":"Pickoff AS, Stolfi A. Modulation of electrophysiological properties of neonatal canine heart by tonic parasympathetic stimulation. Am J Physiol. 1990, 258:H38-44. 10.1152\/ajpheart.1990.258.1.H38","journal-title":"Am J Physiol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2006.07.080","article-title":"Evolutionary aspects of diet, the omega-6\/omega-3 ratio and genetic variation: nutritional implications for chronic diseases","volume":"60","author":"Simopoulos AP","year":"2006","unstructured":"Simopoulos AP. Evolutionary aspects of diet, the omega-6\/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006, 60:502-7. 10.1016\/j.biopha.2006.07.080","journal-title":"Biomed Pharmacother"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04182-23","article-title":"High-fat diet disrupts the gut microbiome, leading to inflammation, damage to tight junctions, and apoptosis and necrosis in Nyctereutes procyonoides intestines","volume":"12","author":"Wei C","year":"2024","unstructured":"Wei C, Xu T, Geng Y, Yang J, Lv H, Guo M-y. High-fat diet disrupts the gut microbiome, leading to inflammation, damage to tight junctions, and apoptosis and necrosis in Nyctereutes procyonoides intestines. Microbiol Spectr. 2024, 12:e0418223. 10.1128\/spectrum.04182-23","journal-title":"Microbiol Spectr"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.04.049","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - a review","volume":"203","author":"Saini RK","year":"2018","unstructured":"Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - a review. Life Sci. 2018, 203:255-67. 10.1016\/j.lfs.2018.04.049","journal-title":"Life Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2007.tb00361.x","article-title":"Dietary lipids in early development and intestinal inflammatory disease","volume":"65","author":"Innis SM","year":"2007","unstructured":"Innis SM, Jacobson K. Dietary lipids in early development and intestinal inflammatory disease. Nutr Rev. 2007, 65:S188-93. 10.1111\/j.1753-4887.2007.tb00361.x","journal-title":"Nutr Rev"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2016.07.002","article-title":"Metabolism and functional effects of plant-derived omega-3 fatty acids in humans","volume":"64","author":"Baker EJ","year":"2016","unstructured":"Baker EJ, Miles EA, Burdge GC, Yaqoob P, Calder PC. Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res. 2016, 64:30-56. 10.1016\/j.plipres.2016.07.002","journal-title":"Prog Lipid Res"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/s0753-3322(02)00253-6","article-title":"The importance of the ratio of omega-6\/omega-3 essential fatty acids","volume":"56","author":"Simopoulos AP","year":"2002","unstructured":"Simopoulos AP. The importance of the ratio of omega-6\/omega-3 essential fatty acids. Biomed Pharmacother. 2002, 56:365-79. 10.1016\/s0753-3322(02)00253-6","journal-title":"Biomed Pharmacother"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang R","year":"2023","unstructured":"Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023, 13:e065186. 10.1136\/bmjopen-2022-065186","journal-title":"BMJ Open"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122619","article-title":"The Imbalance between n-6\/n-3 polyunsaturated fatty acids and inflammatory bowel disease: a comprehensive review and future therapeutic perspectives","volume":"18","author":"Scaioli E","year":"2017","unstructured":"Scaioli E, Liverani E, Belluzzi A. The Imbalance between n-6\/n-3 polyunsaturated fatty acids and inflammatory bowel disease: a comprehensive review and future therapeutic perspectives. Int J Mol Sci. 2017, 18:2619. 10.3390\/ijms18122619","journal-title":"Int J Mol Sci"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.03.013","article-title":"Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity","volume":"8","author":"Pearl DS","year":"2014","unstructured":"Pearl DS, Masoodi M, Eiden M, et al.. Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity. J Crohns Colitis. 2014, 8:70-9. 10.1016\/j.crohns.2013.03.013","journal-title":"J Crohns Colitis"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-157123","article-title":"Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells","volume":"113","author":"Krause P","year":"2009","unstructured":"Krause P, Bruckner M, Uerm\u00f6si C, Singer E, Groettrup M, Legler DF. Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells. Blood. 2009, 113:2451-60. 10.1182\/blood-2008-05-157123","journal-title":"Blood"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03220.x","article-title":"Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation","volume":"130","author":"Arimoto-Miyamoto K","year":"2010","unstructured":"Arimoto-Miyamoto K, Kadowaki N, Kitawaki T, Iwata S, Morimoto C, Uchiyama T. Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation. Immunology. 2010, 130:137-49. 10.1111\/j.1365-2567.2010.03220.x","journal-title":"Immunology"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.034","article-title":"Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn's disease","volume":"146","author":"Costea I","year":"2014","unstructured":"Costea I, Mack DR, Lemaitre RN, Israel D, Marcil V, Ahmad A, Amre DK. Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn's disease. Gastroenterology. 2014, 146:929-31. 10.1053\/j.gastro.2013.12.034","journal-title":"Gastroenterology"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1405790","article-title":"Unraveling the causal link: fatty acids and inflammatory bowel disease","volume":"15","author":"Zhou Y","year":"2024","unstructured":"Zhou Y, Zhou Z. Unraveling the causal link: fatty acids and inflammatory bowel disease. Front Immunol. 2024, 15:1405790. 10.3389\/fimmu.2024.1405790","journal-title":"Front Immunol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.1.200S","article-title":"Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer","volume":"137","author":"Chapkin RS","year":"2007","unstructured":"Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR, McMurray DN. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr. 2007, 137:200S-4S. 10.1093\/jn\/137.1.200S","journal-title":"J Nutr"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000322","article-title":"The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice","volume":"1","author":"Turnbaugh PJ","year":"2009","unstructured":"Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009, 1:6ra14. 10.1126\/scitranslmed.3000322","journal-title":"Sci Transl Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2012.05.003","article-title":"The human gut microbiome: current knowledge, challenges, and future directions","volume":"160","author":"Dave M","year":"2012","unstructured":"Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res. 2012, 160:246-57. 10.1016\/j.trsl.2012.05.003","journal-title":"Transl Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3945\/jn.113.174615","article-title":"High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-\/- male mice","volume":"143","author":"Paik J","year":"2013","unstructured":"Paik J, Fierce Y, Treuting PM, Brabb T, Maggio-Price L. High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-\/- male mice. J Nutr. 2013, 143:1240-7. 10.3945\/jn.113.174615","journal-title":"J Nutr"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e328339536b","article-title":"The intestinal microbiota in inflammatory bowel diseases: time to connect with the host","volume":"26","author":"Sokol H","year":"2010","unstructured":"Sokol H, Seksik P. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol. 2010, 26:327-31. 10.1097\/MOG.0b013e328339536b","journal-title":"Curr Opin Gastroenterol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305304","article-title":"Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease","volume":"63","author":"Ananthakrishnan AN","year":"2014","unstructured":"Ananthakrishnan AN, Khalili H, Konijeti GG, et al.. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut. 2014, 63:776-84. 10.1136\/gutjnl-2013-305304","journal-title":"Gut"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006320.pub4","article-title":"Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease","volume":"2014","author":"Lev-Tzion R","year":"2014","unstructured":"Lev-Tzion R, Griffiths AM, Leder O, Turner D. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2014, 2014:CD006320. 10.1002\/14651858.CD006320.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.192","article-title":"Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study","volume":"105","author":"Jantchou P","year":"2010","unstructured":"Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010, 105:2195-201. 10.1038\/ajg.2010.192","journal-title":"Am J Gastroenterol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6193.762","article-title":"Diet and Crohn's disease: characteristics of the pre-illness diet","volume":"2","author":"Thornton JR","year":"1979","unstructured":"Thornton JR, Emmett PM, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J. 1979, 2:762-4. 10.1136\/bmj.2.6193.762","journal-title":"Br Med J"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200502000-00009","article-title":"Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan","volume":"11","author":"Sakamoto N","year":"2005","unstructured":"Sakamoto N, Kono S, Wakai K, et al.. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005, 11:154-63. 10.1097\/00054725-200502000-00009","journal-title":"Inflamm Bowel Dis"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature","volume":"106","author":"Hou JK","year":"2011","unstructured":"Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011, 106:563-73. 10.1038\/ajg.2011.44","journal-title":"Am J Gastroenterol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01411.x","article-title":"Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children","volume":"102","author":"Amre DK","year":"2007","unstructured":"Amre DK, D'Souza S, Morgan K, et al.. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol. 2007, 102:2016-25. 10.1111\/j.1572-0241.2007.01411.x","journal-title":"Am J Gastroenterol"},{"key":"ref92","article-title":"Dietary habits as risk factors for inflammatory bowel disease","volume":"7","author":"Tragnone A","year":"1995","unstructured":"Tragnone A, Valpiani D, Miglio F, Elmi G, Bazzocchi G, Pipitone E, Lanfranchi GA. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995, 7:47-51.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/32.9.1898","article-title":"Dietary fiber and nutrient intake in Crohn's disease","volume":"32","author":"Kasper H","year":"1979","unstructured":"Kasper H, Sommer H. Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr. 1979, 32:1898-901. 10.1093\/ajcn\/32.9.1898","journal-title":"Am J Clin Nutr"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2008.02.015","article-title":"Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome","volume":"3","author":"Turnbaugh PJ","year":"2008","unstructured":"Turnbaugh PJ, B\u00e4ckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008, 3:213-23. 10.1016\/j.chom.2008.02.015","journal-title":"Cell Host Microbe"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00098.2010","article-title":"Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation","volume":"299","author":"de La Serre CB","year":"2010","unstructured":"de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010, 299:G440-8. 10.1152\/ajpgi.00098.2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2009.112","article-title":"Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice","volume":"4","author":"Zhang C","year":"2010","unstructured":"Zhang C, Zhang M, Wang S, et al.. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2010, 4:232-41. 10.1038\/ismej.2009.112","journal-title":"ISME J"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota S","year":"2012","unstructured":"Devkota S, Wang Y, Musch MW, et al.. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice. Nature. 2012, 487:104-8. 10.1038\/nature11225","journal-title":"Nature"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000798","article-title":"Dairy products, dietary calcium, and risk of inflammatory bowel disease: results from a European prospective cohort investigation","volume":"22","author":"Opstelten JL","year":"2016","unstructured":"Opstelten JL, Leenders M, Dik VK, et al.. Dairy products, dietary calcium, and risk of inflammatory bowel disease: results from a European prospective cohort investigation. Inflamm Bowel Dis. 2016, 22:1403-11. 10.1097\/MIB.0000000000000798","journal-title":"Inflamm Bowel Dis"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1478374","article-title":"Advances in research on the role of high carbohydrate diet in the process of inflammatory bowel disease (IBD)","volume":"15","author":"Zhang Y","year":"2024","unstructured":"Zhang Y, Xun L, Qiao R, et al.. Advances in research on the role of high carbohydrate diet in the process of inflammatory bowel disease (IBD). Front Immunol. 2024, 15:1478374. 10.3389\/fimmu.2024.1478374","journal-title":"Front Immunol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17149","article-title":"Sugar-sweetened beverages, artificially sweetened beverages and natural juices and risk of inflammatory bowel disease: a cohort study of 121,490 participants","volume":"56","author":"Fu T","year":"2022","unstructured":"Fu T, Chen H, Chen X, et al.. Sugar-sweetened beverages, artificially sweetened beverages and natural juices and risk of inflammatory bowel disease: a cohort study of 121,490 participants. Aliment Pharmacol Ther. 2022, 56:1018-29. 10.1111\/apt.17149","journal-title":"Aliment Pharmacol Ther"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.70016","article-title":"Is there an \"optimal\" diet for prevention of inflammatory bowel disease?","volume":"8","author":"Yao CK","year":"2024","unstructured":"Yao CK, Fitzpatrick J, Machado P, Staudacher HM. Is there an \"optimal\" diet for prevention of inflammatory bowel disease?. JGH Open. 2024, 8:e70016. 10.1002\/jgh3.70016","journal-title":"JGH Open"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199307000-00011","article-title":"Dietary intake and nutritional treatment in childhood Crohn's disease","volume":"17","author":"Thomas AG","year":"1993","unstructured":"Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr. 1993, 17:75-81. 10.1097\/00005176-199307000-00011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000638","article-title":"Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC study","volume":"22","author":"Racine A","year":"2016","unstructured":"Racine A, Carbonnel F, Chan SS, et al.. Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC study. Inflamm Bowel Dis. 2016, 22:345-54. 10.1097\/MIB.0000000000000638","journal-title":"Inflamm Bowel Dis"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22964","article-title":"Clostridium difficile infection in the inflammatory bowel disease patient","volume":"19","author":"Berg AM","year":"2013","unstructured":"Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis. 2013, 19:194-204. 10.1002\/ibd.22964","journal-title":"Inflamm Bowel Dis"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.72.3.1729-1738.2006","article-title":"Bile salt hydrolase activity in probiotics","volume":"72","author":"Begley M","year":"2006","unstructured":"Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol. 2006, 72:1729-38. 10.1128\/AEM.72.3.1729-1738.2006","journal-title":"Appl Environ Microbiol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.12.029","article-title":"Avoidance of fiber is associated with greater risk of Crohn's disease flare in a 6-month period","volume":"14","author":"Brotherton CS","year":"2016","unstructured":"Brotherton CS, Martin CA, Long MD, Kappelman MD, Sandler RS. Avoidance of fiber is associated with greater risk of Crohn's disease flare in a 6-month period. Clin Gastroenterol Hepatol. 2016, 14:1130-6. 10.1016\/j.cgh.2015.12.029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3390\/nu12123648","article-title":"Low FODMAP diet for functional gastrointestinal symptoms in quiescent inflammatory bowel disease: a systematic review of randomized controlled trials","volume":"12","author":"Grammatikopoulou MG","year":"2020","unstructured":"Grammatikopoulou MG, Goulis DG, Gkiouras K, et al.. Low FODMAP diet for functional gastrointestinal symptoms in quiescent inflammatory bowel disease: a systematic review of randomized controlled trials. Nutrients. 2020, 12:3648. 10.3390\/nu12123648","journal-title":"Nutrients"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48749-2","article-title":"A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice","volume":"9","author":"Laffin M","year":"2019","unstructured":"Laffin M, Fedorak R, Zalasky A, et al.. A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice. Sci Rep. 2019, 9:12294. 10.1038\/s41598-019-48749-2","journal-title":"Sci Rep"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0022-9","article-title":"The role of diet in the aetiopathogenesis of inflammatory bowel disease","volume":"15","author":"Khalili H","year":"2018","unstructured":"Khalili H, Chan SS, Lochhead P, Ananthakrishnan AN, Hart AR, Chan AT. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2018, 15:525-35. 10.1038\/s41575-018-0022-9","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000168","article-title":"Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis","volume":"20","author":"Chan SS","year":"2014","unstructured":"Chan SS, Luben R, van Schaik F, et al.. Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2014, 20:2013-21. 10.1097\/MIB.0000000000000168","journal-title":"Inflamm Bowel Dis"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001161","article-title":"Dietary iron and heme iron consumption, genetic susceptibility, and risk of crohn's disease and ulcerative colitis","volume":"23","author":"Khalili H","year":"2017","unstructured":"Khalili H, de Silva PS, Ananthakrishnan AN, et al.. Dietary iron and heme iron consumption, genetic susceptibility, and risk of crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2017, 23:1088-95. 10.1097\/MIB.0000000000001161","journal-title":"Inflamm Bowel Dis"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12341","article-title":"Fc\u03b3 receptors: genetic variation, function, and disease","volume":"268","author":"Hargreaves CE","year":"2015","unstructured":"Hargreaves CE, Rose-Zerilli MJ, Machado LR, Iriyama C, Hollox EJ, Cragg MS, Strefford JC. Fc\u03b3 receptors: genetic variation, function, and disease. Immunol Rev. 2015, 268:6-24. 10.1111\/imr.12341","journal-title":"Immunol Rev"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.09.063","article-title":"Diet and inflammatory bowel disease: review of patient-targeted recommendations","volume":"12","author":"Hou JK","year":"2014","unstructured":"Hou JK, Lee D, Lewis J. Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol. 2014, 12:1592-600. 10.1016\/j.cgh.2013.09.063","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref114","article-title":"Bengt E. Gustafsson memorial lecture. Function of the normal human microflora","volume":"49","author":"Gorbach SL","year":"1986","unstructured":"Gorbach SL. Bengt E. Gustafsson memorial lecture. Function of the normal human microflora. Scand J Infect Dis Suppl. 1986, 49:17-30.","journal-title":"Scand J Infect Dis Suppl"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.08.013","article-title":"Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics","volume":"345","author":"Serban DE","year":"2014","unstructured":"Serban DE. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett. 2014, 345:258-70. 10.1016\/j.canlet.2013.08.013","journal-title":"Cancer Lett"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3437-3","article-title":"Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature","volume":"60","author":"Martin TD","year":"2015","unstructured":"Martin TD, Chan SS, Hart AR. Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci. 2015, 60:1396-405. 10.1007\/s10620-014-3437-3","journal-title":"Dig Dis Sci"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74188","article-title":"Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs","volume":"124","author":"Degagn\u00e9 E","year":"2014","unstructured":"Degagn\u00e9 E, Pandurangan A, Bandhuvula P, et al.. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. J Clin Invest. 2014, 124:5368-84. 10.1172\/JCI74188","journal-title":"J Clin Invest"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.11.013","article-title":"Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer","volume":"23","author":"Liang J","year":"2013","unstructured":"Liang J, Nagahashi M, Kim EY, et al.. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013, 23:107-20. 10.1016\/j.ccr.2012.11.013","journal-title":"Cancer Cell"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.11.030","article-title":"Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice","volume":"154","author":"Llewellyn SR","year":"2018","unstructured":"Llewellyn SR, Britton GJ, Contijoch EJ, et al.. Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice. Gastroenterology. 2018, 154:1037-1046.e2. 10.1053\/j.gastro.2017.11.030","journal-title":"Gastroenterology"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05681.x","article-title":"Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis?","volume":"23","author":"Asakura H","year":"2008","unstructured":"Asakura H, Suzuki K, Kitahora T, Morizane T. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis?. J Gastroenterol Hepatol. 2008, 23:1794-801. 10.1111\/j.1440-1746.2008.05681.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199201000-00009","article-title":"Diet and inflammatory bowel disease: a case-control study","volume":"3","author":"Persson PG","year":"1992","unstructured":"Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology. 1992, 3:47-52. 10.1097\/00001648-199201000-00009","journal-title":"Epidemiology"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.6.754","article-title":"Pre-illness dietary factors in inflammatory bowel disease","volume":"40","author":"Reif S","year":"1997","unstructured":"Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997, 40:754-60. 10.1136\/gut.40.6.754","journal-title":"Gut"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000228998.29466.ac","article-title":"Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population","volume":"12","author":"Halfvarson J","year":"2006","unstructured":"Halfvarson J, Jess T, Magnuson A, et al.. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis. 2006, 12:925-33. 10.1097\/01.mib.0000228998.29466.ac","journal-title":"Inflamm Bowel Dis"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00381.x","article-title":"A population-based case control study of potential risk factors for IBD","volume":"101","author":"Bernstein CN","year":"2006","unstructured":"Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006, 101:993-1002. 10.1111\/j.1572-0241.2006.00381.x","journal-title":"Am J Gastroenterol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1159\/000358143","article-title":"Dietary clues to the pathogenesis of Crohn's disease","volume":"32","author":"Pfeffer-Gik T","year":"2014","unstructured":"Pfeffer-Gik T, Levine A. Dietary clues to the pathogenesis of Crohn's disease. Dig Dis. 2014, 32:389-94. 10.1159\/000358143","journal-title":"Dig Dis"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2011.10.001","article-title":"Diet and risk of inflammatory bowel disease","volume":"44","author":"Andersen V","year":"2012","unstructured":"Andersen V, Olsen A, Carbonnel F, Tj\u00f8nneland A, Vogel U. Diet and risk of inflammatory bowel disease. Dig Liver Dis. 2012, 44:185-94. 10.1016\/j.dld.2011.10.001","journal-title":"Dig Liver Dis"},{"key":"ref127","article-title":"A case-control study of ulcerative colitis in relation to dietary and other factors in Japan. The epidemiology G+group of the Research Committee of Inflammatory Bowel Disease in Japan","volume":"30","year":"1995","unstructured":"A case-control study of ulcerative colitis in relation to dietary and other factors in Japan. The epidemiology G+group of the Research Committee of Inflammatory Bowel Disease in Japan.  J Gastroenterol. 1995, 30.9-12.","journal-title":"J Gastroenterol"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1080\/01635580701684872","article-title":"Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence","volume":"60","author":"Santarelli RL","year":"2008","unstructured":"Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer. 2008, 60:131-44. 10.1080\/01635580701684872","journal-title":"Nutr Cancer"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15024-6","article-title":"Crohn's disease: the cold chain hypothesis","volume":"362","author":"Hugot JP","year":"2003","unstructured":"Hugot JP, Alberti C, Berrebi D, Bingen E, Cezard JP. Crohn's disease: the cold chain hypothesis. Lancet. 2003, 362:2012-5. 10.1016\/S0140-6736(03)15024-6","journal-title":"Lancet"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review","volume":"166","author":"Hashash JG","year":"2024","unstructured":"Hashash JG, Elkins J, Lewis JD, Binion DG. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology. 2024, 166:521-32. 10.1053\/j.gastro.2023.11.303","journal-title":"Gastroenterology"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwad041","article-title":"Is the Mediterranean diet in inflammatory bowel diseases ready for prime time?","volume":"7","author":"Godny L","year":"2024","unstructured":"Godny L, Dotan I. Is the Mediterranean diet in inflammatory bowel diseases ready for prime time?. J Can Assoc Gastroenterol. 2024, 7:97-103. 10.1093\/jcag\/gwad041","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980011002515","article-title":"Mediterranean diet pyramid today. Science and cultural updates","volume":"14","author":"Bach-Faig A","year":"2011","unstructured":"Bach-Faig A, Berry EM, Lairon D, et al.. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011, 14:2274-84. 10.1017\/S1368980011002515","journal-title":"Public Health Nutr"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.3390\/foods9081014","article-title":"Bioactive compounds and quality of extra virgin olive oil","volume":"9","author":"Jimenez-Lopez C","year":"2020","unstructured":"Jimenez-Lopez C, Carpena M, Louren\u00e7o-Lopes C, et al.. Bioactive compounds and quality of extra virgin olive oil. Foods. 2020, 9:1014. 10.3390\/foods9081014","journal-title":"Foods"},{"key":"ref134","article-title":"Protein intake and risk of inflammatory bowel disease: a meta-analysis","volume":"31","author":"Zhou XL","year":"2022","unstructured":"Zhou XL, Zhao QQ, Li XF, Li Z, Zhao SX, Li YM. Protein intake and risk of inflammatory bowel disease: a meta-analysis. Asia Pac J Clin Nutr. 2022, 31:443-9.","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.758518","article-title":"Long-term overconsumption of fat and sugar causes a partially reversible pre-inflammatory bowel disease state","volume":"8","author":"Arnone D","year":"2021","unstructured":"Arnone D, Vallier M, Hergalant S, et al.. Long-term overconsumption of fat and sugar causes a partially reversible pre-inflammatory bowel disease state. Front Nutr. 2021, 8:758518. 10.3389\/fnut.2021.758518","journal-title":"Front Nutr"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.05.047","article-title":"A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults With Crohn's disease","volume":"161","author":"Lewis JD","year":"2021","unstructured":"Lewis JD, Sandler RS, Brotherton C, et al.. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults With Crohn's disease. Gastroenterology. 2021, 161:837-52.e9. 10.1053\/j.gastro.2021.05.047","journal-title":"Gastroenterology"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa097","article-title":"Multidimensional impact of Mediterranean diet on IBD patients","volume":"27","author":"Chicco F","year":"2021","unstructured":"Chicco F, Magr\u00ec S, Cingolani A, et al.. Multidimensional impact of Mediterranean diet on IBD patients. Inflamm Bowel Dis. 2021, 27:1-9. 10.1093\/ibd\/izaa097","journal-title":"Inflamm Bowel Dis"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-019-01972-z","article-title":"Adherence to Mediterranean diet in Crohn's disease","volume":"59","author":"Papada E","year":"2020","unstructured":"Papada E, Amerikanou C, Forbes A, Kaliora AC. Adherence to Mediterranean diet in Crohn's disease. Eur J Nutr. 2020, 59:1115-21. 10.1007\/s00394-019-01972-z","journal-title":"Eur J Nutr"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030470","article-title":"From evidence to practice: a narrative framework for integrating the Mediterranean diet into inflammatory bowel disease management","volume":"17","author":"Naik RG","year":"2025","unstructured":"Naik RG, Purcell SA, Gold SL, Christiansen V, D'Aloisio LD, Raman M, Haskey N. From evidence to practice: a narrative framework for integrating the Mediterranean diet into inflammatory bowel disease management. Nutrients. 2025, 17:470. 10.3390\/nu17030470","journal-title":"Nutrients"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012839.pub2","article-title":"Dietary interventions for induction and maintenance of remission in inflammatory bowel disease","volume":"2","author":"Limketkai BN","year":"2019","unstructured":"Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, et al.. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Syst Rev. 2019, 2:CD012839. 10.1002\/14651858.CD012839.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60071106","article-title":"The relationship of adherence to the mediterranean diet with disease activity and quality of life in Crohn's disease patients","volume":"60","author":"Migdanis A","year":"2024","unstructured":"Migdanis A, Migdanis I, Gkogkou ND, et al.. The relationship of adherence to the mediterranean diet with disease activity and quality of life in Crohn's disease patients. Medicina (Kaunas). 2024, 60:1106. 10.3390\/medicina60071106","journal-title":"Medicina (Kaunas)"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.05.006","article-title":"Breaking barriers in dietary research: strategies to diversify recruitment in clinical studies and develop culturally tailored diets for Hispanic communities living with inflammatory bowel disease","volume":"21","author":"Damas OM","year":"2023","unstructured":"Damas OM, Maldonado-Contreras A. Breaking barriers in dietary research: strategies to diversify recruitment in clinical studies and develop culturally tailored diets for Hispanic communities living with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2023, 21:2169-73. 10.1016\/j.cgh.2023.05.006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.10.044","article-title":"Barriers and facilitators to Mediterranean diet adoption by patients with nonalcoholic fatty liver disease in Northern Europe","volume":"17","author":"Haigh L","year":"2019","unstructured":"Haigh L, Bremner S, Houghton D, et al.. Barriers and facilitators to Mediterranean diet adoption by patients with nonalcoholic fatty liver disease in Northern Europe. Clin Gastroenterol Hepatol. 2019, 17:1364-71.e3. 10.1016\/j.cgh.2018.10.044","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2016.11.011","article-title":"Dietary and enteral interventions for Crohn's disease","volume":"44","author":"Yamamoto T","year":"2017","unstructured":"Yamamoto T, Shimoyama T, Kuriyama M. Dietary and enteral interventions for Crohn's disease. Curr Opin Biotechnol. 2017, 44:69-73. 10.1016\/j.copbio.2016.11.011","journal-title":"Curr Opin Biotechnol"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2011.00558.x","article-title":"International survey of enteral nutrition protocols used in children with Crohn's disease","volume":"13","author":"Whitten KE","year":"2012","unstructured":"Whitten KE, Rogers P, Ooi CY, Day AS. International survey of enteral nutrition protocols used in children with Crohn's disease. J Dig Dis. 2012, 13:107-12. 10.1111\/j.1751-2980.2011.00558.x","journal-title":"J Dig Dis"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.3390\/nu16213581","article-title":"Mechanisms of action of exclusive enteral nutrition and other nutritional therapies in Crohn's disease","volume":"16","author":"Geesala R","year":"2024","unstructured":"Geesala R, Gongloor P, Recharla N, Shi XZ. Mechanisms of action of exclusive enteral nutrition and other nutritional therapies in Crohn's disease. Nutrients. 2024, 16:3581. 10.3390\/nu16213581","journal-title":"Nutrients"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1007\/s12263-015-0479-x","article-title":"The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis","volume":"10","author":"Nahidi L","year":"2015","unstructured":"Nahidi L, Corley SM, Wilkins MR, et al.. The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis. Genes Nutr. 2015, 10:479. 10.1007\/s12263-015-0479-x","journal-title":"Genes Nutr"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00419.x","article-title":"The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease","volume":"9","author":"Breese EJ","year":"1995","unstructured":"Breese EJ, Michie CA, Nicholls SW, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther. 1995, 9:547-52. 10.1111\/j.1365-2036.1995.tb00419.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/s0899-9007(97)00493-0","article-title":"Childhood Crohn's disease and the efficacy of enteral diets","volume":"14","author":"Beattie RM","year":"1998","unstructured":"Beattie RM, Bentsen BS, MacDonald TT. Childhood Crohn's disease and the efficacy of enteral diets. Nutrition. 1998, 14:345-50. 10.1016\/s0899-9007(97)00493-0","journal-title":"Nutrition"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1331","article-title":"Exclusive enteral nutrition in active pediatric Crohn disease: effects on intestinal microbiota and immune regulation","volume":"138","author":"Schwerd T","year":"2016","unstructured":"Schwerd T, Frivolt K, Clavel T, et al.. Exclusive enteral nutrition in active pediatric Crohn disease: effects on intestinal microbiota and immune regulation. J Allergy Clin Immunol. 2016, 138:592-6. 10.1016\/j.jaci.2015.12.1331","journal-title":"J Allergy Clin Immunol"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041012","article-title":"Predictors of response to exclusive enteral nutrition in newly diagnosed Crohn\u00b4s disease in children: PRESENCE study from SEGHNP","volume":"12","author":"Moriczi M","year":"2020","unstructured":"Moriczi M, Pujol-Muncunill G, Mart\u00edn-Masot R, et al.. Predictors of response to exclusive enteral nutrition in newly diagnosed Crohn\u00b4s disease in children: PRESENCE study from SEGHNP. Nutrients. 2020, 12:1012. 10.3390\/nu12041012","journal-title":"Nutrients"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03796.x","article-title":"Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease","volume":"28","author":"Leach ST","year":"2008","unstructured":"Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease. Aliment Pharmacol Ther. 2008, 28:724-33. 10.1111\/j.1365-2036.2008.03796.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad158","article-title":"Exclusive enteral nutrition alleviates Th17-mediated inflammation via eliminating mechanical stress-induced Th17-polarizing cytokines in Crohn's-like colitis","volume":"30","author":"Geesala R","year":"2024","unstructured":"Geesala R, Zhang K, Lin YM, Johnson JC, Cong Y, Cohn S, Shi XZ. Exclusive enteral nutrition alleviates Th17-mediated inflammation via eliminating mechanical stress-induced Th17-polarizing cytokines in Crohn's-like colitis. Inflamm Bowel Dis. 2024, 30:429-40. 10.1093\/ibd\/izad158","journal-title":"Inflamm Bowel Dis"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.010","article-title":"Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial","volume":"4","author":"Borrelli O","year":"2006","unstructured":"Borrelli O, Cordischi L, Cirulli M, et al.. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol. 2006, 4:744-53. 10.1016\/j.cgh.2006.03.010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03860.x","article-title":"Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis","volume":"29","author":"Andoh A","year":"2009","unstructured":"Andoh A, Tsujikawa T, Sasaki M, et al.. Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment Pharmacol Ther. 2009, 29:75-82. 10.1111\/j.1365-2036.2008.03860.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04294.x","article-title":"Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach","volume":"21","author":"Day AS","year":"2006","unstructured":"Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol. 2006, 21:1609-14. 10.1111\/j.1440-1746.2006.04294.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1544-3","article-title":"Vitamin D deficiency in children with inflammatory bowel disease","volume":"56","author":"Levin AD","year":"2011","unstructured":"Levin AD, Wadhera V, Leach ST, Woodhead HJ, Lemberg DA, Mendoza-Cruz AC, Day AS. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci. 2011, 56:830-6. 10.1007\/s10620-010-1544-3","journal-title":"Dig Dis Sci"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0165-0","article-title":"Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease","volume":"45","author":"Whitten KE","year":"2010","unstructured":"Whitten KE, Leach ST, Bohane TD, Woodhead HJ, Day AS. Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease. J Gastroenterol. 2010, 45:399-405. 10.1007\/s00535-009-0165-0","journal-title":"J Gastroenterol"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00338.x","article-title":"Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease","volume":"8","author":"Beattie RM","year":"1994","unstructured":"Beattie RM, Schiffrin EJ, Donnet-Hughes A, Huggett AC, Domizio P, MacDonald TT, Walker-Smith JA. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther. 1994, 8:609-15. 10.1111\/j.1365-2036.1994.tb00338.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02002.x","article-title":"Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition","volume":"20","author":"Afzal NA","year":"2004","unstructured":"Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, et al.. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther. 2004, 20:167-72. 10.1111\/j.1365-2036.2004.02002.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1177\/0884533613487218","article-title":"Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease","volume":"28","author":"Guo Z","year":"2013","unstructured":"Guo Z, Wu R, Zhu W, et al.. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease. Nutr Clin Pract. 2013, 28:499-505. 10.1177\/0884533613487218","journal-title":"Nutr Clin Pract"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.09172","article-title":"Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn's disease","volume":"19","author":"Sharma S","year":"2021","unstructured":"Sharma S, Gupta A, Kedia S, et al.. Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn's disease. Intest Res. 2021, 19:291-300. 10.5217\/ir.2019.09172","journal-title":"Intest Res"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2019.03.012","article-title":"The role of exclusive enteral nutrition in the preoperative optimization of laparoscopic surgery for patients with Crohn's disease: a cohort study","volume":"65","author":"Ge X","year":"2019","unstructured":"Ge X, Tang S, Yang X, et al.. The role of exclusive enteral nutrition in the preoperative optimization of laparoscopic surgery for patients with Crohn's disease: a cohort study. Int J Surg. 2019, 65:39-44. 10.1016\/j.ijsu.2019.03.012","journal-title":"Int J Surg"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01634-1","article-title":"Efficacy of enteral nutrition in patients with Crohn's disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis","volume":"55","author":"Hirai F","year":"2020","unstructured":"Hirai F, Takeda T, Takada Y, et al.. Efficacy of enteral nutrition in patients with Crohn's disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis. J Gastroenterol. 2020, 55:133-41. 10.1007\/s00535-019-01634-1","journal-title":"J Gastroenterol"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i43.7652","article-title":"Use of exclusive enteral nutrition in adults with Crohn's disease: a review","volume":"19","author":"Wall CL","year":"2013","unstructured":"Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn's disease: a review. World J Gastroenterol. 2013, 19:7652-60. 10.3748\/wjg.v19.i43.7652","journal-title":"World J Gastroenterol"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17451","article-title":"Review article: mechanisms underlying the effectiveness of exclusive enteral nutrition in Crohn's disease","volume":"57","author":"Melton SL","year":"2023","unstructured":"Melton SL, Taylor KM, Gibson PR, Halmos EP. Review article: mechanisms underlying the effectiveness of exclusive enteral nutrition in Crohn's disease. Aliment Pharmacol Ther. 2023, 57:932-47. 10.1111\/apt.17451","journal-title":"Aliment Pharmacol Ther"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000110","article-title":"Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease","volume":"20","author":"Sigall-Boneh R","year":"2014","unstructured":"Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis. 2014, 20:1353-60. 10.1097\/MIB.0000000000000110","journal-title":"Inflamm Bowel Dis"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.3390\/nu16070987","article-title":"Is there evidence of Crohn's disease exclusion diet (CDED) in remission of active disease in children and adults? A systematic review","volume":"16","author":"Correia I","year":"2024","unstructured":"Correia I, Oliveira PA, Antunes ML, Raimundo MD, Moreira AC. Is there evidence of Crohn's disease exclusion diet (CDED) in remission of active disease in children and adults? A systematic review. Nutrients. 2024, 16:987. 10.3390\/nu16070987","journal-title":"Nutrients"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315866","article-title":"Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases","volume":"67","author":"Levine A","year":"2018","unstructured":"Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018, 67:1726-38. 10.1136\/gutjnl-2017-315866","journal-title":"Gut"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.3390\/nu13114112","article-title":"Effectiveness of Crohn's disease exclusion diet for induction of remission in Crohn's disease adult patients","volume":"13","author":"Szczube\u0142ek M","year":"2021","unstructured":"Szczube\u0142ek M, Pomorska K, Kor\u00f3lczyk-Kowalczyk M, Lewandowski K, Kaniewska M, Rydzewska G. Effectiveness of Crohn's disease exclusion diet for induction of remission in Crohn's disease adult patients. Nutrients. 2021, 13:10.3390\/nu13114112","journal-title":"Nutrients"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00299-5","article-title":"The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial","volume":"7","author":"Yanai H","year":"2022","unstructured":"Yanai H, Levine A, Hirsch A, et al.. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial. Lancet Gastroenterol Hepatol. 2022, 7:49-59. 10.1016\/S2468-1253(21)00299-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx071","article-title":"Dietary therapy with the Crohn's disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy","volume":"11","author":"Sigall Boneh R","year":"2017","unstructured":"Sigall Boneh R, Sarbagili Shabat C, Yanai H, Chermesh I, Ben Avraham S, Boaz M, Levine A. Dietary therapy with the Crohn's disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy. J Crohns Colitis. 2017, 11:1205-12. 10.1093\/ecco-jcc\/jjx071","journal-title":"J Crohns Colitis"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-019-03520-7","article-title":"Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study","volume":"179","author":"Urlep D","year":"2020","unstructured":"Urlep D, Benedik E, Brecelj J, Orel R. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study. Eur J Pediatr. 2020, 179:431-8. 10.1007\/s00431-019-03520-7","journal-title":"Eur J Pediatr"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.12.004","article-title":"ESPEN guideline on clinical nutrition in inflammatory bowel disease","volume":"42","author":"Bischoff SC","year":"2023","unstructured":"Bischoff SC, Bager P, Escher J, et al.. ESPEN guideline on clinical nutrition in inflammatory bowel disease. Clin Nutr. 2023, 42:352-79. 10.1016\/j.clnu.2022.12.004","journal-title":"Clin Nutr"},{"key":"ref175","article-title":"Overview of total parenteral nutrition in patients with inflammatory bowel disease","volume":"18","author":"Boutte HJ","year":"2022","unstructured":"Boutte HJ. Overview of total parenteral nutrition in patients with inflammatory bowel disease. Gastroenterol Hepatol (N.Y.). 2022, 18:50-3.","journal-title":"Gastroenterol Hepatol (N.Y.)"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.3390\/nu16142288","article-title":"Parenteral nutrition, inflammatory bowel disease, and gut barrier: an intricate plot","volume":"16","author":"Covello C","year":"2024","unstructured":"Covello C, Becherucci G, Di Vincenzo F, et al.. Parenteral nutrition, inflammatory bowel disease, and gut barrier: an intricate plot. Nutrients. 2024, 16:2288. 10.3390\/nu16142288","journal-title":"Nutrients"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz160","article-title":"Perioperative dietary therapy in inflammatory bowel disease","volume":"14","author":"Adamina M","year":"2020","unstructured":"Adamina M, Gerasimidis K, Sigall-Boneh R, et al.. Perioperative dietary therapy in inflammatory bowel disease. J Crohns Colitis. 2020, 14:431-44. 10.1093\/ecco-jcc\/jjz160","journal-title":"J Crohns Colitis"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.11178","article-title":"The use of parenteral nutrition in patients with inflammatory bowel disease: a detailed guide on the indications, risks, and benefits","volume":"39","author":"Kohler D","year":"2024","unstructured":"Kohler D, Freid H, Cholewka J, Miller M, Gold SL. The use of parenteral nutrition in patients with inflammatory bowel disease: a detailed guide on the indications, risks, and benefits. Nutr Clin Pract. 2024, 39:1026-36. 10.1002\/ncp.11178","journal-title":"Nutr Clin Pract"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac085","article-title":"Use and misuse of parenteral nutrition in patients with inflammatory bowel disease","volume":"28","author":"Nelson AD","year":"2022","unstructured":"Nelson AD, Elkins JR, Stocchi L, Farraye FA, Hashash JG. Use and misuse of parenteral nutrition in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2022, 28:1592-602. 10.1093\/ibd\/izac085","journal-title":"Inflamm Bowel Dis"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2019.11.002","article-title":"ESPEN practical guideline: clinical nutrition in inflammatory bowel disease","volume":"39","author":"Bischoff SC","year":"2020","unstructured":"Bischoff SC, Escher J, H\u00e9buterne X, et al.. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2020, 39:632-53. 10.1016\/j.clnu.2019.11.002","journal-title":"Clin Nutr"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-318172","article-title":"Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure","volume":"69","author":"Pironi L","year":"2020","unstructured":"Pironi L, Steiger E, Joly F, et al.. Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure. Gut. 2020, 69:1787-95. 10.1136\/gutjnl-2018-318172","journal-title":"Gut"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06140-6","article-title":"Teduglutide promotes epithelial tight junction pore function in murine short bowel syndrome to alleviate intestinal insufficiency","volume":"65","author":"Reiner J","year":"2020","unstructured":"Reiner J, Berlin P, Wobar J, et al.. Teduglutide promotes epithelial tight junction pore function in murine short bowel syndrome to alleviate intestinal insufficiency. Dig Dis Sci. 2020, 65:3521-37. 10.1007\/s10620-020-06140-6","journal-title":"Dig Dis Sci"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.11015","article-title":"Use of teduglutide in adults with short bowel syndrome-associated intestinal failure","volume":"39","author":"Pironi L","year":"2024","unstructured":"Pironi L, Allard JP, Joly F, Geransar P, Genestin E, Pape UF. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure. Nutr Clin Pract. 2024, 39:141-53. 10.1002\/ncp.11015","journal-title":"Nutr Clin Pract"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.648954","article-title":"Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition","volume":"47","author":"Jacobson S","year":"2012","unstructured":"Jacobson S. Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition. Scand J Gastroenterol. 2012, 47:170-7. 10.3109\/00365521.2011.648954","journal-title":"Scand J Gastroenterol"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/61.18.1938","article-title":"Metabolic complications of parenteral nutrition in adults, part 1","volume":"61","author":"Btaiche IF","year":"2004","unstructured":"Btaiche IF, Khalidi N. Metabolic complications of parenteral nutrition in adults, part 1. Am J Health Syst Pharm. 2004, 61:1938-49. 10.1093\/ajhp\/61.18.1938","journal-title":"Am J Health Syst Pharm"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.2478\/pjs-2014-0021","article-title":"Cholelithiasis in home parenteral nutrition (Hpn) patients--complications of the clinical nutrition: diagnosis, treatment, prevention","volume":"86","author":"Lawi\u0144ski M","year":"2014","unstructured":"Lawi\u0144ski M, Jachnis A, Ukleja A, Pertkiewicz M. Cholelithiasis in home parenteral nutrition (Hpn) patients--complications of the clinical nutrition: diagnosis, treatment, prevention. Pol Przegl Chir. 2014, 86:111-5. 10.2478\/pjs-2014-0021","journal-title":"Pol Przegl Chir"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.11068","article-title":"Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease","volume":"38","author":"Fansiwala K","year":"2023","unstructured":"Fansiwala K, Shah ND, McNulty KA, Kwaan MR, Limketkai BN. Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease. Nutr Clin Pract. 2023, 38:1282-95. 10.1002\/ncp.11068","journal-title":"Nutr Clin Pract"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab219","article-title":"Western and carnivorous dietary patterns are associated with greater likelihood of IBD development in a large prospective population-based cohort","volume":"16","author":"Peters V","year":"2022","unstructured":"Peters V, Bolte L, Schuttert EM, Andreu-S\u00e1nchez S, Dijkstra G, Weersma RK, Campmans-Kuijpers MJ. Western and carnivorous dietary patterns are associated with greater likelihood of IBD development in a large prospective population-based cohort. J Crohns Colitis. 2022, 16:931-9. 10.1093\/ecco-jcc\/jjab219","journal-title":"J Crohns Colitis"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2012.01.014","article-title":"Endoscopic assessment of inflammatory bowel disease: colonoscopy\/esophagogastroduodenoscopy","volume":"41","author":"Chan G","year":"2012","unstructured":"Chan G, Fefferman DS, Farrell RJ. Endoscopic assessment of inflammatory bowel disease: colonoscopy\/esophagogastroduodenoscopy. Gastroenterol Clin North Am. 2012, 41:271-90. 10.1016\/j.gtc.2012.01.014","journal-title":"Gastroenterol Clin North Am"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2015.13.1.19","article-title":"Intestinal stricture in Crohn's disease","volume":"13","author":"Chang CW","year":"2015","unstructured":"Chang CW, Wong JM, Tung CC, Shih IL, Wang HY, Wei SC. Intestinal stricture in Crohn's disease. Intest Res. 2015, 13:19-26. 10.5217\/ir.2015.13.1.19","journal-title":"Intest Res"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz DA","year":"2002","unstructured":"Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002, 122:875-80. 10.1053\/gast.2002.32362","journal-title":"Gastroenterology"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2004.10.012","article-title":"Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications","volume":"37","author":"Papi C","year":"2005","unstructured":"Papi C, Festa V, Fagnani C, et al.. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Dig Liver Dis. 2005, 37:247-53. 10.1016\/j.dld.2004.10.012","journal-title":"Dig Liver Dis"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10608","article-title":"Nutrition management of the high-output fistulae","volume":"36","author":"Couper C","year":"2021","unstructured":"Couper C, Doriot A, Siddiqui MT, Steiger E. Nutrition management of the high-output fistulae. Nutr Clin Pract. 2021, 36:282-96. 10.1002\/ncp.10608","journal-title":"Nutr Clin Pract"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2014.4955","article-title":"Effects of enteral nutritional support on malnourished patients with inflammatory bowel disease by subjective global assessment","volume":"25","author":"S\u00f6k\u00fclmez P","year":"2014","unstructured":"S\u00f6k\u00fclmez P, Demirba\u011f AE, Arslan P, Di\u015fibeyaz S. Effects of enteral nutritional support on malnourished patients with inflammatory bowel disease by subjective global assessment. Turk J Gastroenterol. 2014, 25:493-507. 10.5152\/tjg.2014.4955","journal-title":"Turk J Gastroenterol"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm T","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia MI, et al.. GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019, 10:207-17. 10.1002\/jcsm.12383","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac102","article-title":"High prevalence of malnutrition and micronutrient deficiencies in patients with inflammatory bowel disease early in disease course","volume":"29","author":"Gold SL","year":"2023","unstructured":"Gold SL, Rabinowitz LG, Manning L, et al.. High prevalence of malnutrition and micronutrient deficiencies in patients with inflammatory bowel disease early in disease course. Inflamm Bowel Dis. 2023, 29:423-9. 10.1093\/ibd\/izac102","journal-title":"Inflamm Bowel Dis"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180036","article-title":"Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease","volume":"12","author":"Bamba S","year":"2017","unstructured":"Bamba S, Sasaki M, Takaoka A, et al.. Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease. PLoS One. 2017, 12:e0180036. 10.1371\/journal.pone.0180036","journal-title":"PLoS One"},{"key":"ref198","article-title":"CONUT: a tool for controlling nutritional status. First validation in a hospital population","author":"Ignacio de Ulibarri J","year":"2005","unstructured":"Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, et al.. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005, 38-45.","journal-title":"Nutr Hosp"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020372","article-title":"Nutritional aspects in inflammatory bowel diseases","volume":"12","author":"Balestrieri P","year":"2020","unstructured":"Balestrieri P, Ribolsi M, Guarino MP, Emerenziani S, Altomare A, Cicala M. Nutritional aspects in inflammatory bowel diseases. Nutrients. 2020, 12:372. 10.3390\/nu12020372","journal-title":"Nutrients"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114516003044","article-title":"Inflammation-driven malnutrition: a new screening tool predicts outcome in Crohn's disease","volume":"116","author":"Jansen I","year":"2016","unstructured":"Jansen I, Prager M, Valentini L, B\u00fcning C. Inflammation-driven malnutrition: a new screening tool predicts outcome in Crohn's disease. Br J Nutr. 2016, 116:1061-7. 10.1017\/S0007114516003044","journal-title":"Br J Nutr"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1159\/000485637","article-title":"Nutritional screening and clinical outcome in hospitalized patients with Crohn's disease","volume":"71","author":"Takaoka A","year":"2017","unstructured":"Takaoka A, Sasaki M, Nakanishi N, Kurihara M, Ohi A, Bamba S, Andoh A. Nutritional screening and clinical outcome in hospitalized patients with Crohn's disease. Ann Nutr Metab. 2017, 71:266-72. 10.1159\/000485637","journal-title":"Ann Nutr Metab"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000226","article-title":"Micronutrient deficiencies in inflammatory bowel disease","volume":"18","author":"Weisshof R","year":"2015","unstructured":"Weisshof R, Chermesh I. Micronutrient deficiencies in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2015, 18:576-81. 10.1097\/MCO.0000000000000226","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22906","article-title":"Micronutrient deficiencies in inflammatory bowel disease: from A to zinc","volume":"18","author":"Hwang C","year":"2012","unstructured":"Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012, 18:1961-81. 10.1002\/ibd.22906","journal-title":"Inflamm Bowel Dis"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1038\/scsandc.2016.6","article-title":"Can vitamin B12 deficiency manifest with acute posterolateral or posterior cord syndrome?","volume":"2","author":"Pandey S","year":"2016","unstructured":"Pandey S, V Holla V, Rizvi I, Qavi A, Shukla R. Can vitamin B12 deficiency manifest with acute posterolateral or posterior cord syndrome?. Spinal Cord Ser Cases. 2016, 2:16006. 10.1038\/scsandc.2016.6","journal-title":"Spinal Cord Ser Cases"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5511-x","article-title":"Copper deficiency myelopathy","volume":"257","author":"Jaiser SR","year":"2010","unstructured":"Jaiser SR, Winston GP. Copper deficiency myelopathy. J Neurol. 2010, 257:869-81. 10.1007\/s00415-010-5511-x","journal-title":"J Neurol"},{"key":"ref206","doi-asserted-by":"publisher","DOI":"10.3390\/nu15081991","article-title":"Nutritional status and its detection in patients with inflammatory bowel diseases","volume":"15","author":"Jab\u0142o\u0144ska B","year":"2023","unstructured":"Jab\u0142o\u0144ska B, Mrowiec S. Nutritional status and its detection in patients with inflammatory bowel diseases. Nutrients. 2023, 15:1991. 10.3390\/nu15081991","journal-title":"Nutrients"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.12.027","article-title":"ESPEN guideline: clinical nutrition in inflammatory bowel disease","volume":"36","author":"Forbes A","year":"2017","unstructured":"Forbes A, Escher J, H\u00e9buterne X, et al.. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017, 36:321-47. 10.1016\/j.clnu.2016.12.027","journal-title":"Clin Nutr"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16329","article-title":"Associations between vitamin D, bone mineral density, and the course of inflammatory bowel disease in Polish patients","volume":"132","author":"Ratajczak AE","year":"2022","unstructured":"Ratajczak AE, Szymczak-Tomczak A, Michalak M, Rychter AM, Zawada A, Dobrowolska A, Krela-Ka\u017amierczak I. Associations between vitamin D, bone mineral density, and the course of inflammatory bowel disease in Polish patients. Pol Arch Intern Med. 2022, 132:10.20452\/pamw.16329","journal-title":"Pol Arch Intern Med"},{"key":"ref209","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096096","article-title":"Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis","volume":"28","author":"Ringstad J","year":"1993","unstructured":"Ringstad J, Kildebo S, Thomassen Y. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand J Gastroenterol. 1993, 28:605-8. 10.3109\/00365529309096096","journal-title":"Scand J Gastroenterol"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/74.2.259","article-title":"Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease","volume":"74","author":"Wendland BE","year":"2001","unstructured":"Wendland BE, Aghdassi E, Tam C, et al.. Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr. 2001, 74:259-64. 10.1093\/ajcn\/74.2.259","journal-title":"Am J Clin Nutr"},{"key":"ref211","doi-asserted-by":"publisher","DOI":"10.3390\/nu4091247","article-title":"Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand","volume":"4","author":"Gentschew L","year":"2012","unstructured":"Gentschew L, Bishop KS, Han DY, et al.. Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand. Nutrients. 2012, 4:1247-59. 10.3390\/nu4091247","journal-title":"Nutrients"},{"key":"ref212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jand.2019.04.013","article-title":"Nutrition assessment in Crohn's disease using anthropometric, biochemical, and dietary indexes: a narrative review","volume":"120","author":"Sandall AM","year":"2020","unstructured":"Sandall AM, Wall CL, Lomer MC. Nutrition assessment in Crohn's disease using anthropometric, biochemical, and dietary indexes: a narrative review. J Acad Nutr Diet. 2020, 120:624-40. 10.1016\/j.jand.2019.04.013","journal-title":"J Acad Nutr Diet"},{"key":"ref213","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200105000-00003","article-title":"Zinc supplementation tightens \"leaky gut\" in Crohn's disease","volume":"7","author":"Sturniolo GC","year":"2001","unstructured":"Sturniolo GC, Di Leo V, Ferronato A, D'Odorico A, D'Inc\u00e0 R. Zinc supplementation tightens \"leaky gut\" in Crohn's disease. Inflamm Bowel Dis. 2001, 7:94-8. 10.1097\/00054725-200105000-00003","journal-title":"Inflamm Bowel Dis"},{"key":"ref214","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40139","article-title":"Selenium deficiency in inflammatory bowel disease: a comprehensive meta-analysis","volume":"10","author":"Liu S","year":"2024","unstructured":"Liu S, Lin T, Wang W, Jing F, Sheng J. Selenium deficiency in inflammatory bowel disease: a comprehensive meta-analysis. Heliyon. 2024, 10:e40139. 10.1016\/j.heliyon.2024.e40139","journal-title":"Heliyon"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31825959b8","article-title":"Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations","volume":"55","author":"Rufo PA","year":"2012","unstructured":"Rufo PA, Denson LA, Sylvester FA, et al.. Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. J Pediatr Gastroenterol Nutr. 2012, 55:93-108. 10.1097\/MPG.0b013e31825959b8","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref216","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50139","article-title":"American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation","volume":"124","year":"2003","unstructured":"American Gastroenterological Association medical position statement. short bowel syndrome and intestinal transplantation. Gastroenterology. 2003, 124:1105-10. 10.1053\/gast.2003.50139","journal-title":"Gastroenterology"},{"key":"ref217","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2017.99","article-title":"Body composition assessment of Crohn's outpatients and comparison with gender- and age-specific multiple matched control pairs","volume":"71","author":"Moln\u00e1r A","year":"2017","unstructured":"Moln\u00e1r A, Csontos \u00c1A, Kov\u00e1cs I, Anton \u00c1D, P\u00e1lfi E, Miheller P. Body composition assessment of Crohn's outpatients and comparison with gender- and age-specific multiple matched control pairs. Eur J Clin Nutr. 2017, 71:1246-50. 10.1038\/ejcn.2017.99","journal-title":"Eur J Clin Nutr"},{"key":"ref218","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.022","article-title":"Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project working group","volume":"156","author":"Mahadevan U","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N, et al.. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project working group. Gastroenterology. 2019, 156:1508-24. 10.1053\/j.gastro.2018.12.022","journal-title":"Gastroenterology"},{"key":"ref219","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1873948","article-title":"Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis","volume":"20","author":"Laube R","year":"2021","unstructured":"Laube R, Paramsothy S, Leong RW. Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis. Expert Opin Drug Saf. 2021, 20:275-92. 10.1080\/14740338.2021.1873948","journal-title":"Expert Opin Drug Saf"},{"key":"ref220","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i37.13219","article-title":"Crohn's disease and growth deficiency in children and adolescents","volume":"20","author":"Gasparetto M","year":"2014","unstructured":"Gasparetto M, Guariso G. Crohn's disease and growth deficiency in children and adolescents. World J Gastroenterol. 2014, 20:13219-33. 10.3748\/wjg.v20.i37.13219","journal-title":"World J Gastroenterol"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn's disease","volume":"8","author":"Ruemmele FM","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, et al.. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 2014, 8:1179-207. 10.1016\/j.crohns.2014.04.005","journal-title":"J Crohns Colitis"},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4586-6","article-title":"Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis","volume":"29","author":"Szafors P","year":"2018","unstructured":"Szafors P, Che H, Barnetche T, Morel J, Gaujoux-Viala C, Combe B, Lukas C. Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis. Osteoporos Int. 2018, 29:2389-97. 10.1007\/s00198-018-4586-6","journal-title":"Osteoporos Int"},{"key":"ref223","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16580","article-title":"Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels","volume":"54","author":"Sleutjes JA","year":"2021","unstructured":"Sleutjes JA, Roeters van Lennep JE, Boersma E, et al.. Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels. Aliment Pharmacol Ther. 2021, 54:999-1012. 10.1111\/apt.16580","journal-title":"Aliment Pharmacol Ther"},{"key":"ref224","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300988","article-title":"Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options","volume":"61","author":"Siegel CA","year":"2012","unstructured":"Siegel CA. Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options. Gut. 2012, 61:459-65. 10.1136\/gutjnl-2011-300988","journal-title":"Gut"},{"key":"ref225","doi-asserted-by":"publisher","DOI":"10.3390\/nu16183184","article-title":"Cultural perspectives on the efficacy and adoption of the Crohn's disease exclusion diet across diverse ethnicities: a case-based overview","volume":"16","author":"Sigall Boneh R","year":"2024","unstructured":"Sigall Boneh R, Park S, Soledad Arcucci M, et al.. Cultural perspectives on the efficacy and adoption of the Crohn's disease exclusion diet across diverse ethnicities: a case-based overview. Nutrients. 2024, 16:3184. 10.3390\/nu16183184","journal-title":"Nutrients"},{"key":"ref226","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001545","article-title":"Digital health technologies for remote monitoring and management of inflammatory bowel disease: a systematic review","volume":"117","author":"Nguyen NH","year":"2022","unstructured":"Nguyen NH, Martinez I, Atreja A, Sitapati AM, Sandborn WJ, Ohno-Machado L, Singh S. Digital health technologies for remote monitoring and management of inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2022, 117:78-97. 10.14309\/ajg.0000000000001545","journal-title":"Am J Gastroenterol"},{"key":"ref227","doi-asserted-by":"publisher","DOI":"10.2196\/14630","article-title":"Digital health apps in the clinical care of inflammatory bowel disease: scoping review","volume":"21","author":"Yin AL","year":"2019","unstructured":"Yin AL, Hachuel D, Pollak JP, Scherl EJ, Estrin D. Digital health apps in the clinical care of inflammatory bowel disease: scoping review. J Med Internet Res. 2019, 21:e14630. 10.2196\/14630","journal-title":"J Med Internet Res"},{"key":"ref228","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2023.12.027","article-title":"Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn's disease","volume":"119","author":"Nichols B","year":"2024","unstructured":"Nichols B, Briola A, Logan M, et al.. Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn's disease. Am J Clin Nutr. 2024, 119:885-95. 10.1016\/j.ajcnut.2023.12.027","journal-title":"Am J Clin Nutr"},{"key":"ref229","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00002.2022","article-title":"Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?","volume":"323","author":"L\u00ea A","year":"2022","unstructured":"L\u00ea A, Mantel M, Marchix J, Bodinier M, Jan G, Rolli-Derkinderen M. Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?. Am J Physiol Gastrointest Liver Physiol. 2022, 323:G523-53. 10.1152\/ajpgi.00002.2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref230","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.06.068","article-title":"CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease","volume":"163","author":"Ma C","year":"2022","unstructured":"Ma C, Hanzel J, Panaccione R, et al.. CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease. Gastroenterology. 2022, 163:950-64. 10.1053\/j.gastro.2022.06.068","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/378494-the-role-of-diet-in-crohns-disease-from-etiology-to-evidence-based-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T05:52:29Z","timestamp":1751089949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/378494-the-role-of-diet-in-crohns-disease-from-etiology-to-evidence-based-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":230,"URL":"https:\/\/doi.org\/10.7759\/cureus.86891","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}